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Acceleration of MRP-associated efflux of rhodamine 123 by genistein and
related compounds
CHM Versantvoort, T Rhodes and PR Twentyman
Medical Research Council, Clinical Oncology and Radiotherapeutics Unit, Hills Road, Cambridge CB2 2QH, UK.
Summary Multidrug resistance (MDR), caused by overexpression of either P-glycoprotein or the multidrug
resistance protein (MRP), is characterised by a decreased cellular drug accumulation due to an enhanced drug
efflux. In this study, we examined the effects of genistein and structurally related (iso)flavonoids on the
transport of rhodamine 123 (Rhl23) and daunorubicin in the MRP-overexpressing MDR lung cancer cell lines
COR-L23/R and MOR/R. Genistein, genistin, daidzein and quercetin showed major differences in effects on
Rhl23 vs daunorubicin transport in the MRP-mediated MDR cell lines: the accumulation of daunorubicin was
increased, whereas the accumulation of Rhl23 was decreased by the flavonoids. The depolarisation of the
membrane potential caused by genistein might be involved in the acceleration of the efflux of Rhl23 measured
in the MRP-overexpressing cell lines. These observations should be taken into account when using fluorescent
dyes as probes for determination of transporter activity as a measure of MDR.
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Treatment of cancer cell lines with one of a group of natural
cytotoxic drugs, such as the anthracyclines, vinca alkaloids
and epipodophyllotoxins, frequently results in cross-resis-
tance to the other drugs. In many of these multidrug-
resistant (MDR) cells, resistance is caused by reduced
intracellular drug levels owing to the overexpression of
plasma membrane drug transporters. Up to now, two
different plasma membrane drug transporters have been
shown to confer MDR in human tumour cell lines, namely
P-glycoprotein (P-gp), encoded by the MDR-J gene
(Gottesman and Pastan, 1993), and the multidrug resis-
tance-associated protein, MRP (Cole et al., 1992). In
addition to the cytotoxic drugs themselves, a number of
fluorescent dyes are being used as probes in the study of
transporter activity. One such probe, Rh123, is very
efficiently transported by P-gp, resulting in a larger
accumulation deficit than that for doxorubicin and
daunorubicin. The use of Rhl23 has, therefore, been
suggested to be a useful approach for the determination of
P-gp activity in human haemopoietic malignancies
(Chaudhary and Roninson, 1993). Recently, we have shown
that Rhl23 is a substrate not only for P-gp but also for
MRP (Twentyman et al., 1994). Expression of both P-gp
and MRP has been reported to occur in malignant
haemopoietic cells (Schuurhuis et al., 1995). Therefore,
transport of Rhl23 in such cells may be influenced both
by MRP and by P-gp.
Recently, it has been shown that, in addition to the
hydrophobic agents which are effluxed from both P-gp- and
MRP-overexpressing cells, anions, such as leukotriene C4
and glutathione S-conjugates, are transported by MRP
(Jedlitschky et al., 1994; Muller et al,. 1994). MRP has,
therefore, been suggested to be the glutathione S-conjugate
transporter present in a variety of normal cell types.
Furthermore, glutathione depletion inhibits MRP- but not
P-gp-mediated drug transport (Lutzky et al., 1989;
Versantvoort et al., 1995). On the other hand, Pgp-MDR
modifiers, such as verapamil, cyclosporin A and PSC833, are
less effective in MRP-overexpressing cell lines (Barrand et
al., 1993). Thus, methods to circumvent resistance show such
an important difference between the two transporters.
We have shown previously that the efflux of daunorubicin
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in several MRP-overexpressing MDR cell lines is inhibited by
the isoflavonoid genistein (Versantvoort et al., 1993). In
contrast, the activity of P-gp appears to be up-regulated by
several flavonoids (Critchfield et al., 1994). Therefore, we
thought that genistein might be a useful agent in facilitating
discrimination between P-gp- and MRP-mediated Rh123
transport. In this study, we have examined the modulation
of Rhl23 transport by genistein and three other
(iso)flavonoids in two MDR lung cancer cell lines that
overexpress MRP. The study showed that the transport of
Rhl23 and of daunorubicin in MRP-overexpressing MDR
cell lines is affected differently by (iso)flavonoids.
Materials and methods
Chemicals
Daunorubicin hydrochloride and rhodamine 123 were obtained
from Sigma (Poole, Dorset, UK). [G-3H]Daunorubicin
hydrochloride (sp. act. 3.6 Ci mmol-') was obtained from
NEN-DuPont de Nemours (Stevenage, UK). Chemicals used
as potential modifers, together with the names ofsuppliers and
solvents used were: genistein, genistin and quercetin [Sigma;
dimethyl sulphoxide (DMSO)]; daidzein (Extrasynthese,
Genay, France; DMSO); DL-buthionine-S,R-sulphoximine
[Sigma; phosphate-buffered saline (PBS)]; verapamil hydro-
chloride (Baker Norton, Harlow, UK; sterile water); cyclos-
porin A (Sandoz, Basle, Switzerland; 100% ethanol). The
structures of the (iso)flavonoids are depicted in Figure 1.
DiOC5 and DIDS were obtained from Molecular Probes
(Eugene, OR, USA) and Sigma respectively. Appropriate
solvent controls were used in all experiments.
Cells
In this study, the following human lung tumour cell lines
were used: the large-cell lung cancer cell line COR-L23/P, the
adenocarcinoma cell line MOR/P and the small-cell lung
cancer cell line H69/P, together with their doxorubicin-
selected MDR variants COR-L23/R, MOR/R and H69/LX4
(Twentyman et al., 1986; Barrand et al., 1994). The MDR
COR-L23/R and MOR-R cell lines overexpress the MRP but
not the MDR-1 gene (Barrand et al., 1994). For comparison,
the P-gp-overexpressing H69/LX4 cell line was used
(Twentyman et al, 1986). Cell lines were cultured in RPMI-
1640 medium supplemented with penicillin (100 U ml-1),
streptomycin (100 U ml-') and 10% fetal bovine serum (allEnhanced Rhl23 transport by genistein
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Figure 1 Chemical structures of the (iso)flavonoids. Genistein,
genistin and daidzein are isoflavonoids, whereas quercetin is a
flavonoid.
from Sigma). The resistant sublines were cultured in
doxorubicin-containing medium until 2-7 days before
experiments.
Cellular drug transport
Cells (0.1 x 106 per sample) were incubated with 0.5 gM
[3H]daunorubicin or 0.1 Mg ml-' Rh123 for various time
periods at 37°C as described previously (Versantvoort et al.,
1995). The accumulation of drugs was then stopped by two
ice-cold washes with PBS, and cellular drug content was
determined by liquid scintillation counting (for daunorubicin)
or by flow cytometry (for Rh123, excitation at 488 nm and
emission above 630 nm). Values were corrected for amount
of cell-associated drugs at time zero at 0°C. For determina-
tion of Rh123 efflux, cells were resuspended in drug-free
medium in the presence or absence of modifier after loading
for 60 min with 0.1 Mug ml-' Rh123.
Membrane potential
The fluorescent probe, DiOC5, was used to measure the
membrane potential. Cells were loaded with 0.1 gM DiOC5
for 15 min (steady state) in the presence or absence of 200 Mm
genistein or 100 gM DIDS. Cells were then washed with PBS
and the accumulation of DiOC5 was determined by flow
cytometry with excitation at 488 nm and fluorescence
emission measured above 530 nm.
Results
Effect offiavonoids on daunorubicin accumulation in MDR
cells
Since genistein was shown to inhibit the efflux ofdaunorubicin
in several MRP- but not in P-gp-overexpressing MDR cells
(Versantvoort et al., 1993), we first determined the effects of
genistein and three other (iso)flavonoids on the daunorubicin
accumulation in two MRP-overexpressing MDR cell lines,
COR-L23/R and MOR/R [which do not overexpress P-gp
(Barrand et al., 1994)], and in the P-gp-overexpressing MDR
cell line, H69/LX4. Structures of the (iso)flavonoids are
depicted in Figure 1. Genistein increased the daunorubicin
accumulation in a concentration-dependent manner in the
MRP-MDR COR-L23/R cell line with a maximal effect at
200-400 LM genistein (data not shown). For further
experiments, 200 gM flavonoid was used, since this concentra-
tion could be obtained with < 0.5% DMSO. Figure 2 shows
the effect of the flavonoids on the daunorubicin accumulation
in MRP- and P-gp-MDR cell lines. All four (iso)flavonoids
increased the daunorubicin accumulation in the MRP-MDR
cell lines, with genistein being the most effective modulator.
Only small effects of the flavonoids were seen in the parental
cell lines. Genistein, quercetin and daidzein did not increase
the daunorubicin accumulation in the P-gp-MDR H69/LX4
cell line, which is in accordance with our previous data for
genistein in P-gp-MDR cell lines (Versantvoort et al., 1993). In
contrast, genistin almost completely reversed the daunorubicin
accumulation deficit in the H69/LX4 cells.
Effect offlavonoids on Rh123 transport
We then examined the effects of genistein on the
accumulation and efflux of Rhl23 in the COR-L23 cells. It
can be seen from Figure 3a that genistein decreased the
accumulation of Rh123 in the MRP-MDR COR-L23/R cell
line. This is in contrast to the effects of genistein on the
daunorubicin accumulation (Figure 2). Since genistein had
no effect on the accumulation of Rh123 in the parental
COR-L23/P cells during this time period, it is unlikely that
the decrease in Rh123 accumulation in the resistant cells is a
result of a change in the passive transport of Rh123 by
genistein.
Since the accumulation deficit of Rhl23 in the COR-L23/
R cells is caused by an enhanced Rh123 efflux from the
resistant cells (Twentyman et al., 1994), we measured the
effect of genistein on the efflux of Rhl23. Figure 3b shows
that genistein immediately accelerated the efflux of Rh123
from the resistant COR-L23/R cells. A similar efflux
experiment was performed in MOR cells and genistein also
accelerated the Rh123 efflux in the resistant cells of this line
(Figure 4). The effects on Rh123 efflux were apparent within
5 min of administration of genistein in the resistant cell lines,
whereas genistein reduced the retention of Rh123 in the
parental cell lines significantly at time points beyond 90 min.
Semi-logarithmic plotting of the retention data revealed that
the efflux of Rh123 followed first-order kinetics in the
resistant cells. Genistein enhanced the efflux of Rhi23 3- to
5-fold in the resistant COR-L23/R and MOR/R cell lines, as
well to some extent (<2-fold) in the parental MOR/P cells
(Table I).
Next, we measured the concentration-dependent effect of
genistein on Rh123 retention. Figure 5 shows a gradual
decrease in Rh123 retention with increasing genistein
concentrations in COR-L23/R cells with a maximal effect at
100-200 gM genistein. Only the highest genistein concentra-
tion had a significant effect in the COR-L23/P cells.
We then examined the effect of the other flavonoids on the
retention of Rh123 and compared the effects with those of
the resistance modifiers, verapamil, cyclosporin A and
buthionine sulphoximine (BSO), as well as the cytotoxic
agent vinblastine. Results for the COR-L23/R cells are shown
in Figure 6. Treatment with BSO was given for 20 h before
Rh123 retention was determined; the other modulators wereEnhanced Rhl23 transport by genistein
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added only during the efflux period. It can be seen that all
modifiers, as well as the cytotoxic agent vinblastine, inhibited
the efflux of Rhl23 from the COR-L23/R cells. All the
(iso)flavonoids tested decreased the retention of Rhl23 in
COR-L23/R cells, although genistin was only slightly active.
Quercetin decreased the retention in the parental COR-L23/P
cells to some extent, although less than in the resistant cells.
Effect of membrane potential on Rh123 transport
Since the enhancement of the Rhl23 efflux by the
(iso)flavonoids is in contrast with the inhibition of the efflux
of the cytotoxic agents, daunorubicin, doxorubicin and VP-16
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Figure 2 Modulation of daunorubicin (DNR) accumulation by
(iso)flavonoids. Cells were incubated with 0.5 gM [3H]daunorubicin
for 60min in the presence of 200 pM flavonoid or vehicle. Without
modifer present, the daunorubicin accumulation in the resistant
cell lines ( ) was decreased to 37%, 21% and 25% in the COR-
L23/R (a), MOR/R (b) and H69/LX4 (c) cells, respectively,
compared with the accumulation in their parental cell lines (Ei).
Data are expressed as daunorubicin accumulation in the presence
of modifier divided by daunorubicin accumulation with vehicle
(0.5% DMSO) x 100%. Results are mean+s.d. of at least three
experiments.
Figure 3 Effect of genistein on Rhl23 transport in COR-L23
cells. (a) COR-L23/P (0O0) and COR-L23/R (A,A) were
exposed to 0.1 pgml-1 Rhl23 in the presence of 200gM genistein
(-,A) or vehicle (0.5% DMSO, 0,,). Each point is mean+s.d.
of three experiments. In each experiment, values were calculated
relative to the fluorescence of the Rhl23 accumulation in COR-
L23/P cells at t=60min, which was chosen as 100%. (b) For the
efflux of Rhl23, cells were incubated with Rhl23 in the absence
of genistein for 1 h, washed and resuspended in medium with
(0,A) or without (0,A) 200pM genistein. Each point is
mean+s.d. of three experiments.
Daidzemn
0
8
-
c 0
8
.2
U
o. E
4-
0
U
o
7_
E
.8
4.5
cJ
v
.5
C
0,
0
C'
0.
.E
a U
a
z a3Enhanced Rh123 transport by genistein
CHM Versantvoort et a!
1952
Table I Effect of genistein on t1/2 of rhodamine 123 efflux
t1/2 (min)
Control Genistein (200ymM)
COR-L23/P > 300 (3) > 200 (3)
COR-L23/R 51 +4 (3) 11 +3 (3)a
MOR/P 185, 235 116, 119
MOR/R 25±4 (4) 9+2 (3)
aData are significantly different from control, P < 0.02, Student's t-
test. Semi-logarithmic plotting of the retention data showed that the
efflux of Rhl23 from the resistant cells followed first-order kinetics
(correlation coefficient r2=0.99 during 2h of Rhl23 efflux or to 10%
of the starting Rhl23 content, whichever occurs first). Number of
experiments in parentheses, except where only two experiments were
carried out in which case individual values are shown.
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(Versantvoort et al., 1993), we considered the possibility that
alterations in the accumulation of Rhl23 rather than
stimulation of the activity of the drug transporter causes
the accelerated efflux of Rhl23 by genistein. Because Rhl23
depends for its accumulation on the mitochondrial membrane
potential, we compared the effects of sodium azide, which is
known to disrupt the mitochondrial membrane potential,
with the effects of genistein. Sodium azide concentrations
were chosen such that cellular ATP levels were not depleted
to such a degree as to influence the transport of drugs
(Versantvoort et al., 1994). The effects of sodium azide on
Rhl23 efflux are shown in Figure 7. It can be seen that
25 mm sodium azide accelerated the efflux of Rhl23 to a
degree similar to the effect of genistein.
This effect of sodium azide might suggest that the
acceleration of the Rhl23 efflux by genistein is caused by
alterations in the membrane potential. Therefore, we
measured the membrane potential with the fluorescent probe
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Figure 4 Effect of genistein on Rh123 transport in MOR cells.
MOR/P cells (OS) and MOR/R cells (/A,) were incubated
with Rh123 in the absence of genistein for 1 h, washed and
resuspended in medium with (@,A) or without (O,A) 200,uM
genistein. Each point is mean+s.d. of three experiments.
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Figure 5 Dose - response of genistein on Rh123 retention in
COR-L23 cells. COR-L23/P (=I) and COR-L23/R (El2) were
loaded for 60min with 0.1 Mgml- Rh123 followed by efflux of
Rh123 for 60min. Results are mean+s.d. of at least three
experiments.
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Figure 6 Effect of flavonoids and other modulators on Rh123
retention. Retention (60min) of Rh123 was measured (a) in the
presence of 10Mm verapamil (Vp), 4.2UM cyclosporin A (CsA),
11 Mm vinblastine (VBL), 200Mm genistein (GEN) and 25,UM
buthionine sulphoximine (BSO, 20h preincubation), or (b) in
the presence of 200MM genistein, genistin, quercetin and daidzein
in COR-L23/P (MII) and COR-L23/R cells (E1). Data are
mean+s.d. of at least three experiments.
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Figure 7 Modulation of Rhl23 efflux by sodium azide in COR-
L23/R cells. Cells were incubated for 60min with 0.1 jIgml-
Rhl23 followed by an efflux of Rhl23 in the absence (0) or
presence of genistein (0) or 5mm sodium azide (A) or 25mM
sodium azide (i). Each point is mean+s.d. of three experiments.
DiOC5. The accumulation of DiOC5 was rapid (steady state
was reached in 15 min) and similar in the parental and the
resistant COR-L23 cell lines (not shown). We then examined
the effects of genistein on the accumulation of DiOC5. As a
comparison 100 jgM DIDS, which is known to depolarise the
membrane potential, was included in the experiments. DIDS,
as well as genistein, decreased the accumulation of DiOC5 to
60-72% of control in the COR-L23 cell lines. Depolarisation
of the membrane potential by genistein was similar in
parental and resistant cells, 66% and 60% respectively.
Discussion
The plasma membrane protein P-gp is well known for its
prominent role as a drug efflux pump in the MDR
phenotype. Overexpression of MRP in tumour cell lines
involves cross-resistance to similar cytotoxic drugs, such as
daunorubicin, doxorubicin, vincristine, colchicine and etopo-
side, owing to an enhanced efflux of the drugs out of the
cells (Zaman et al., 1994; Grant et al., 1994). Absolute
discrimination between P-gp- and MRP-mediated resistance
appears currently not to be achievable based on functional
drug transport assays. However, the effects of various
resistance modifiers vary considerably between the two
types of MDR. Recently, we have shown that the
isoflavonoid genistein and cellular glutathione depletion are
potent inhibitors of MRP- but not P-gp-mediated daunor-
ubicin transport (Versantvoort et al., 1993, 1995). Moreover,
Phang et al. (1993) showed that P-gp-mediated efflux was
accelerated by flavonoids. Since glutathione depletion by
buthionine sulphoximine takes several hours (Versantvoort
et al., 1995), genistein is potentially more useful in a
functional assay to discriminate between P-gp- and MRP-
mediated resistance.
In this study, the accumulation of daunorubicin was
increased by genistein in the MRP-overexpressing MDR cell
lines only (Figure 2), which is in accordance with our
previous results (Versantvoort et al., 1993). Of note was the
reversal of the accumulation deficit of daunorubicin in the P-
gp-overexpressing H69/LX4 cell line by genistin (Figure 2),
since none of the (iso)flavonoids tested by Critchfield et al.
(1994) was able to increase the accumulation of doxorubicin
in the P-gp-expressing HCT-15 colon cells efficiently. The fact
that genistin and genistein differ only by a glucose unit might
have important implications, since many of the flavonoids
found in fruits and vegetables are present as conjugates/
glycosides (Hermann, 1976).
Furthermore, we were surprised by our finding that the
efflux of Rhl23 in the MRP-MDR cells was accelerated by
genistein and the other (iso)flavonoids. This is in marked
contrast to our previous results for daunorubicin, doxor-
ubicin and VP-16 (Versantvoort et al., 1993), indicating that
the interaction between genistein and Rh123 is clearly
different from that involving the cytotoxic drugs. We have
shown in the GLC4/ADR MRP-MDR cells that genistein is a
competitive inhibitor of the daunorubicin efflux, indicating an
interaction of genistein at the drug-binding site (Versantvoort
et al., 1994). The different effects of genistein might suggest
that the drug-binding site at the transporter is different for
daunorubicin and Rh123. Since other modifiers affect Rh123
transport in a similar way to the effects previously found for
daunorubicin and vincristine transport (Barrand et al., 1993),
other mechanisms might evoke the acceleration of Rh123
transport in MRP-MDR cells.
An alternative mode of interaction between genistein and
Rh123 was suggested by the observation that sodium azide,
which lowers the mitochondrial membrane potential, was
able to stimulate the efflux of Rh123 (Figure 7). The
depolarisation of the membrane potential caused by
genistein is then likely to affect the transport of Rh123.
The different effects of genistein on the transport of Rh123
and daunorubicin in MRP-overexpressing MDR cells can be
explained by the fact that Rh123, but not daunorubicin, is
depending for its accumulation on the membrane potential.
However, if depolarisation of the membrane potential rather
than stimulation of MRP activity causes the alterations in
Rh123 accumulation, it is then necessary to account for the
different effects of genistein in parental and resistant COR-
L23 cells, as depolarisation of the membrane potential by
genistein was similar in the parental and resistant cells. The
answer might be found in the different kinetics of Rhl23 in
the parental and resistant cells. Transport of Rhl23 over the
plasma membrane is determined by passive diffusion in the
COR-L23/P cells and by a passive and active component in
the COR-L23/R cells. Depolarisation of the membrane
potential will affect passive as well as active transport of
RhI23. Since the efflux of Rh123 is 6- to 10-fold faster from
the resistant cells (active and passive transport) than from
the parental cells (passive transport), the effects caused by
depolarisation of the membrane potential will be apparent
much faster in the resistant cells. As shown in Figures 3 and
4, the effects of genistein on Rh123 efflux are apparent in
the resistant cells within 5 min of administration, whereas
the effects on the parental cells were only significant at
120 min efflux or longer (data not shown).
It may be concluded from our results that the
mechanism(s) by which flavonoids interact with drug
transport is rather complex; not only was the daunorubicin
transport mediated by P-gp and MRP affected differently by
the flavonoids, but genistein and genistin had opposite effects
on the daunorubicin transport mediated by P-gp, and the
flavonoids had opposite effects on the transport of
daunorubicin and Rh123 in MRP-overexpressing cells. These
results show that the use of a more sensitive and/or cheaper
probe (in this case Rh123) instead of the cytotoxic agent itself
for selection of the most efficient resistance modifier must be
regarded with caution, since the effects of modifiers on the
probe may not predict for effects on cytotoxic agents.
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